Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AngioDynamics, a provider of medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, has completed the acquisition of Oncobionic.
Subscribe to our email newsletter
Under the agreement, AngioDynamics has acquired Oncobionic for a total purchase price of $25.4 million, including approximately $400,000 of assumed liabilities. A deposit of $5 million was paid in October 2006 and $10 million was paid at the closing on May 9, 2008. An additional $5 million is due in November 2008 and the final installment of $5 million will be paid in November 2009.
Eamonn Hobbs, president and CEO of AngioDynamics, said: “The closing of the Oncobionic acquisition is a significant landmark for our company as we build upon on our reputation of providing breakthrough innovative technology, while diversifying our business lines and strengthening our strong IP portfolio.”